| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC7335 | URB-597 Featured | URB597 is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. |
|
| DC10286 | Vaborbactam Featured | Vaborbactam is a cyclic boronic acid pharmacophore β-lactamase inhibitor. |
|
| DC10339 | Vadadustat Featured | Vadadustat is a novel, titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor in development for the treatment of anemia. |
|
| DCAPI1041 | Valaciclovir HCl | Valaciclovir HCl |
|
| DC7777 | Valategrast (R411) | Valategrast (R411), a small molecule antagonist of α4β1 integrin, represents a potential therapy for asthma |
|
| DC9816 | Valbenazine（NBI-98854） Featured | Valbenazine(NBI-98854) is a potent and selective VMAT2 inhibitor.. |
|
| DCAPI1452 | Valsartan | Valsartan is a nonpeptide angiotensin II AT1-receptor antagonist with an IC50 ranging from 39.5 to 116 μM. This in turn causes blood vessel dilation. |
|
| DC9813 | Valspodar(PSC833) Featured | Valspodar(PSC833) is a P-glycoprotein (P-gp) inhibitor widely used in preclinical and clinical studies for overcoming multidrug resistance (MDR). |
|
| DC8115 | Vancomycin hydrochloride Featured | Vancomycin hydrochloride in stock,price: 500 USD/100mg. 0 |
|
| DC3134 | Vandetanib (ZD6474) Featured | Vandetanib (Zactima, ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM. |
|
| DC8916 | Vanoxerine dihydrochloride Featured | Vanoxerine 2 Hcl(GBR12909) is a potent and selective DRI (Dopamine reuptake inhibitor). |
|
| DC7607 | Vatalanib Featured | Vatalanib (PTK787) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM, less potent against VEGFR1/Flt-1, 18-fold against VEGFR3/Flt-4. Phase 1/2. |
|
| DC8655 | Vatalanib free base | Vatalanib free base (PTK787 free base) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM, less potent against VEGFR1/Flt-1, 18-fold against VEGFR3/Flt-4. |
|
| DC10104 | VX222(Lomibuvir) Featured | VCH-222(Lomibuvir) is a novel, potent and selective inhibitor of HCV polymerase with IC50 of 0.94-1.2 μM, 15.3-fold less effective for mutant M423T, and 108-fold less effective for mutant I482L. |
|
| DC8899 | ABT888 (free base) Featured | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively. |
|
| DC5150 | Veliparib (ABT-888 hydrochloride) Featured | Veliparib is a potent inhibitor of both PARP-1 and PARP-2 by [3H]NAD+ with Kis of 5.2 and 2.9 nmol/L, respectively. |
|
| DC9751 | Velpatasvir(GS5816) Featured | Velpatasvir(GS-5816) is a potent and selective Hepatitis C virus NS5A inhibitor. |
|
| DC8429 | Verdinexor (KPT-335) Featured | Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor. |
|
| DC12267 | Verdiperstat (AZD3241) Featured | Verdiperstat is a selective, irreversible and orally active myeloperoxidase inhibitor, with an IC50 of 630 nM, and is used in the research of neurodegenerative brain disorders. |
|
| DC10029 | Verinurad Featured | Verinurad is an urate transporter inhibitor with EC50 value of 0.05 μM.Verinurad is useful in the modulation of blood or serum uric acid levels, reducing serum uric acid levels in a human. |
|
| DC7336 | Vicriviroc maleate(Sch-417690) Featured | Vicriviroc Malate is a potent CKR-5 (CCR5) antagonist with IC50 of 0.91 nM. |
|
| DC4184 | Vinorelbine Ditartrate Featured | Vinorelbine (Navelbine) is an anti-mitotic agent which inhibits the proliferation of Hela cells with IC50 of 1.25 nM. |
|
| DC4232 | Vismodegib (GDC-0449) Featured | Vismodegib (formerly GDC-0449) is a hedgehog antagonist, is also an orally bioavailable small molecule with potential antineoplastic activity. |
|
| DC10642 | VLX1570 | VLX1570 is a competitive inhibitor of proteasome DUB activity, with an IC50 of ~10 μM in vitro. |
|
| DC7187 | Volasertib(BI6727) Featured | Volasertib(BI6727) is a highly potent PLK1 inhibitor with an IC50 of 0.87 nM; shows 6- and 65-fold greater selectivity against Plk2 and Plk3. |
|
| DC7530 | Voreloxin Featured | Voreloxin(SNS-595; AG 7352) is a small molecule and a naphthyridine analogue with antineoplastic activity; inhibitor of Topo II. |
|
| DCAPI1451 | Voriconazole Featured | Voriconazole is an ergosterol biosynthesis inhibitor, as well as systemic antifungal. This compound, like many antifungal agents, is an inhibitor of CYP2C9, an enzyme involved in the oxidative metabolism of many xenobiotics. |
|
| DC8252 | Vorinostat (SAHA) Featured | Vorinostat (SAHA) is an HDAC1/3 inhibitor with IC50 of ~10 nM. |
|
| DC10750 | Voruciclib Featured | Voruciclib is a protein kinase inhibitor specific for the cyclin-dependent kinase 4 (CDK4) with potential antineoplastic activity. |
|
| DC8884 | Voxtalisib (XL765, SAR245409) Featured | Voxtalisib (SAR245409, XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. |
|
